tazarotene

(redirected from Fabior)
Also found in: Dictionary.

tazarotene

 [tah-zar´o-tēn]
a retinoidprodrug used topically in treatment of acne vulgaris and psoriasis.
Miller-Keane Encyclopedia and Dictionary of Medicine, Nursing, and Allied Health, Seventh Edition. © 2003 by Saunders, an imprint of Elsevier, Inc. All rights reserved.

tazarotene

Allergan®, Tazorac®, Zorac® Dermatology A topical, receptor-selective retinoid–vitamin A analog–used to manage stable plaque psoriasis, acne vulgaris, BCC. See Basal cell carcinoma, Retinoid.
McGraw-Hill Concise Dictionary of Modern Medicine. © 2002 by The McGraw-Hill Companies, Inc.

tazarotene

A RETINOID drug used externally to treat PSORIASIS. A brand name is Zorac.
Collins Dictionary of Medicine © Robert M. Youngson 2004, 2005
References in periodicals archive ?
In addition there are a number of other ongoing clinical trials assessing the efficacy and tolerability of new indications or label extensions for products like SUBA-itraconazole, FABIOR, LEXETTE and SORILUX, some of which are investigator initiated studies.
Both Fabior and Sorilux will be marketed through Mayne Pharma's Specialty Brands Division and existing sales team.
M2 EQUITYBITES-May 14, 2012-Stiefela[euro](tm)s Fabior Foam receives US FDA approval(C)2012 M2 COMMUNICATIONS http://www.m2.com
Dermatology and skin science company Stiefel, a division of GlaxoSmithKline plc (NYSE:GSK) (LSE:GSK.L), announced on Friday that the US Food and Drug Administration has approved the New Drug Application for Fabior (tazarotene) Foam 0.1%.